Clarivate Plc (CLVT)

Delivering World-class Solutions and Services to Drive Academic Success LONDON , Aug. 14, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading provider of transformative intelligence, has signed an agreement with the University of Melbourne, Australia's leading university, to provide a comprehensive suite of library solutions and services. The solutions include Alma, Primo, Leganto, Rapido and Library Open Workflows, encompassing library management systems, information resource discovery, sharing and subject reading lists.

Integrated into Cortellis Regulatory Intelligence, new AI capability helps regulatory teams streamline access to critical intelligence and understand requirements with ease LONDON , Aug. 14, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the beta launch of its AI-powered Regulatory Assistant within Cortellis Regulatory Intelligence. This new capability is designed to help regulatory professionals navigate complex and evolving global requirements with greater ease, speed and confidence.

LONDON , Aug. 8, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Matti Shem Tov, Chief Executive Officer, and Jonathan Collins, Executive Vice President and Chief Financial Officer, will present at the Oppenheimer 28th Annual Technology, Internet & Communications Virtual Conference, on Wednesday, August 13, 2025 at 12:25 pm Eastern Time. The live webcast can be accessed at https://wsw.com/webcast/oppenheimer43/clvt/2801835 and will be available for replay.

Clarivate is a turnaround story with a strong recurring revenue base, but faces integration issues, high debt, and negative growth. The new CEO's transformation plan focuses on cost-cutting, portfolio simplification, and debt reduction to unlock value and restore growth. Valuation is cheap at 8.5x EV/EBITDA, reflecting market skepticism; upside exists if Clarivate delivers on margin and growth improvements.

Clarivate's organic growth is accelerating, with two consecutive quarters of positive momentum and improving annualized contract value, validating the turnaround thesis. The business is shifting toward higher-quality, recurring revenue streams, de-risking the model and enhancing long-term profitability and cash flow visibility. AI adoption is gaining traction, with over 4,800 institutions using Clarivate's AI tools, strengthening customer stickiness and opening up premium upsell opportunities.

Clarivate Plc (NYSE:CLVT ) Q2 2025 Earnings Conference Call July 30, 2025 9:00 AM ET Company Participants Jonathan M. Collins - Executive VP & CFO Mark J.

While the top- and bottom-line numbers for Clarivate (CLVT) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Clarivate PLC (CLVT) came out with quarterly earnings of $0.18 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.2 per share a year ago.

LONDON , July 30, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced that Maroun S. Mourad will join the Company as President of the Intellectual Property (IP) segment, effective September 8, 2025.

— Continued acceleration of organic ACV and recurring organic revenue growth — — Delivered improved organic recurring revenue mix — — Reaffirmed 2025 Outlook — — Repurchased 11.5 million ordinary shares in the second quarter— LONDON , July 30, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the second quarter ended June 30, 2025. Total revenues for the second quarter of 2025 were $621.4 million, compared to total revenues of $650.3 million for the second quarter of 2024, due to inorganic divestitures and disposals.

New Data Reveals Shifting Global Partnerships, Rising Open Access, and Focus on SDG-Aligned Research LONDON , July 9, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today published its annual G20 research and innovation scorecard, developed by expert analysts and data scientists at the Institute for Scientific Information (ISI) at Clarivate. This interactive scorecard offers a comprehensive, data-driven view of the research and innovation capabilities of G20 member nations.

LONDON , July 8, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the second quarter 2025 before the market opens on Wednesday, July 30, 2025. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com.

50th Anniversary Year Sees Strengthened Focus on Research Integrity LONDON , June 18, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released the 2025 update to the Journal Citation Reports (JCR). This is the 50th anniversary of the industry-leading annual reports, which provide a comprehensive overview of the world's leading and trusted academic journals, offering academic institutions, researchers, and publishers the ability to gauge journals' trustworthiness and impact.

New Report Highlights Emerging Leaders Advancing Next-generation Radiopharmaceuticals, Reshaping Cancer Care Through Targeted Innovation and Strategic Growth LONDON , June 16, 2025 /PRNewswire/ --  Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the release of a new Companies to Watch report, Radioligand Innovators Ushering in a New Era of Precision Oncology . The report spotlights pioneering companies that are redefining the drug discovery and development landscape through advancements in radioligand therapies (RLTs)—a rapidly evolving class of therapeutics that combines nuclear medicine with precision-targeted biotechnology to treat cancer with heightened specificity.

LONDON , June 9, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a new milestone in its decades-long partnership with the American Library Association (ALA). Clarivate will be the first sponsor of the ALA Public Supporter Program, which engages the public in supporting libraries and library professionals.

Web of Science Provides Expanded Access to Essential Research Tools and Data for Canadian Libraries and Research Institutions LONDON , June 3, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a multi-year partnership with the Canadian Research Knowledge Network (CRKN), a consortium of libraries and research institutions in Canada. The agreement provides 55 Canadian universities with expanded access to the Web of Science and is designed to enhance inter-member research collaborations, improving accessibility to Web of Science content for all members.